Methodologies for and Evaluation of Efficacy of Antifungal and Antibiofilm Agents and Surface Coatings Against Fungal Biofilms

Unlike superficial fungal infections of the skin and nails, which are the most common fungal diseases in humans, invasive fungal infections carry high morbidity and mortality, particularly those associated with biofilm formation on indwelling medical devices. Therapeutic management of these complex diseases is often complicated by the rise in resistance to the commonly used antifungal agents. Therefore, the availability of accurate susceptibility testing methods for determining antifungal resistance, as well as discovery of novel antifungal and antibiofilm agents, are key priorities in medical mycology research. To direct advancements in this field, here we present an overview of the methods currently available for determining (i) the susceptibility or resistance of fungal isolates or biofilms to antifungal or antibiofilm compounds and compound combinations; (ii) the efficacy of antifungal and antibiofilm compounds and compound combinations; and (iii) the and performance of anti-infective coatings and materials to prevent fungal biofilm-based infections.

Citing Articles

Antifungal peptides from living organisms.

Gong Y, Xue Q, Li J, Zhang S Front Microbiol. 2025; 15:1511461.

PMID: 39741586 PMC: 11685209. DOI: 10.3389/fmicb.2024.1511461.

Chemical profile, antioxidant, antifungal, and cytotoxic activities of propolis from the stingless bee Tetragona clavipes.

Bergamini A, de Almeida Bergamini B, Pessoa I, de Sousa Cutrim T, Dos Santos T, Dos Santos M Braz J Microbiol. 2024; 56(1):251-262.

PMID: 39673050 PMC: 11885680. DOI: 10.1007/s42770-024-01591-9.

Azole Combinations and Multi-Targeting Drugs That Synergistically Inhibit .

Toepfer S, Keniya M, Lackner M, Monk B J Fungi (Basel). 2024; 10(10).

PMID: 39452650 PMC: 11508803. DOI: 10.3390/jof10100698.

Randomised-crossover clinical trial on the substantivity of a single application of a gel containing chlorhexidine and o-cymen-5-ol on the oral biofilm and saliva.

Suarez-Rodriguez B, Regueira-Iglesias A, Blanco-Pintos T, Sanchez-Barco A, Vila-Blanco N, Balsa-Castro C BMC Oral Health. 2024; 24(1):1247.

PMID: 39427170 PMC: 11490038. DOI: 10.1186/s12903-024-05042-7.

Chiral Fluorescent Antifungal Azole Probes Detect Resistance, Uptake Dynamics, and Subcellular Distribution in Species.

Koren V, Ben-Zeev E, Voronov I, Fridman M JACS Au. 2024; 4(8):3157-3169.

PMID: 39211628 PMC: 11350599. DOI: 10.1021/jacsau.4c00479.

References

Lelievre B, Legras P, Godon C, Franconi F, Saint-Andre J, Bouchara J . Experimental models of disseminated scedosporiosis with cerebral involvement. J Pharmacol Exp Ther. 2013; 345(2):198-205. DOI: 10.1124/jpet.112.201541. View

Larsen R, Bauer M, Thomas A, Graybill J . Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis. Antimicrob Agents Chemother. 2004; 48(3):985-91. PMC: 353060. DOI: 10.1128/AAC.48.3.985-991.2004. View

Shimamura T, Kubota N, Nagasaka S, Suzuki T, Mukai H, Shibuya K . Establishment of a novel model of onychomycosis in rabbits for evaluation of antifungal agents. Antimicrob Agents Chemother. 2011; 55(7):3150-5. PMC: 3122464. DOI: 10.1128/AAC.00399-11. View

Kucharikova S, Sharma N, Spriet I, Maertens J, Van Dijck P, Lagrou K . Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model. Antimicrob Agents Chemother. 2013; 57(5):2365-8. PMC: 3632894. DOI: 10.1128/AAC.02288-12. View

Gomez-Lopez A, Forastiero A, Cendejas-Bueno E, Gregson L, Mellado E, Howard S . An invertebrate model to evaluate virulence in Aspergillus fumigatus: the role of azole resistance. Med Mycol. 2014; 52(3):311-9. DOI: 10.1093/mmy/myt022. View

Scorneaux B, Angulo D, Borroto-Esoda K, Ghannoum M, Peel M, Wring S . SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies. Antimicrob Agents Chemother. 2017; 61(3). PMC: 5328566. DOI: 10.1128/AAC.01961-16. View

Sobel J . Management of patients with recurrent vulvovaginal candidiasis. Drugs. 2003; 63(11):1059-66. DOI: 10.2165/00003495-200363110-00002. View

Morace G, Perdoni F, Borghi E . Antifungal drug resistance in Candida species. J Glob Antimicrob Resist. 2016; 2(4):254-259. DOI: 10.1016/j.jgar.2014.09.002. View

van de Lagemaat M, Grotenhuis A, van de Belt-Gritter B, Roest S, Loontjens T, Busscher H . Comparison of methods to evaluate bacterial contact-killing materials. Acta Biomater. 2017; 59:139-147. DOI: 10.1016/j.actbio.2017.06.042. View

10.

Delattin N, De Brucker K, De Cremer K, Cammue B, Thevissen K . Antimicrobial Peptides as a Strategy to Combat Fungal Biofilms. Curr Top Med Chem. 2016; 17(5):604-612. DOI: 10.2174/1568026616666160713142228. View

11.

Wu T, Hu W, Guo L, Finnegan M, Bradshaw D, Webster P . Development of a new model system to study microbial colonization on dentures. J Prosthodont. 2013; 22(5):344-50. DOI: 10.1111/jopr.12002. View

12.

Vanherp L, Poelmans J, Hillen A, Govaerts K, Belderbos S, Buelens T . Bronchoscopic fibered confocal fluorescence microscopy for longitudinal in vivo assessment of pulmonary fungal infections in free-breathing mice. Sci Rep. 2018; 8(1):3009. PMC: 5813038. DOI: 10.1038/s41598-018-20545-4. View

13.

Sangalli-Leite F, Scorzoni L, de Paula E Silva A, da Silva J, de Oliveira H, Singulani J . Synergistic effect of pedalitin and amphotericin B against Cryptococcus neoformans by in vitro and in vivo evaluation. Int J Antimicrob Agents. 2016; 48(5):504-511. DOI: 10.1016/j.ijantimicag.2016.07.025. View

14.

Klepser M, Ernst E, Lewis R, Ernst M, Pfaller M . Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrob Agents Chemother. 1998; 42(5):1207-12. PMC: 105779. DOI: 10.1128/AAC.42.5.1207. View

15.

Kim W, Hendricks G, Lee K, Mylonakis E . An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs. Expert Opin Drug Discov. 2017; 12(6):625-633. DOI: 10.1080/17460441.2017.1319358. View

16.

Colley T, Sehra G, Chowdhary A, Alanio A, Kelly S, Kizawa Y . and Efficacy of a Novel and Long-Acting Fungicidal Azole, PC1244, on Aspergillus fumigatus Infection. Antimicrob Agents Chemother. 2018; 62(5). PMC: 5923123. DOI: 10.1128/AAC.01941-17. View

17.

Silva-Dias A, Miranda I, Branco J, Cobrado L, Monteiro-Soares M, Pina-Vaz C . In vitro antifungal activity and in vivo antibiofilm activity of cerium nitrate against Candida species. J Antimicrob Chemother. 2015; 70(4):1083-93. DOI: 10.1093/jac/dku511. View

18.

LaFleur M, Qi Q, Lewis K . Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob Agents Chemother. 2009; 54(1):39-44. PMC: 2798516. DOI: 10.1128/AAC.00860-09. View

19.

Johnson C, Yu A, Lee H, Fidel Jr P, Noverr M . Development of a contemporary animal model of Candida albicans-associated denture stomatitis using a novel intraoral denture system. Infect Immun. 2012; 80(5):1736-43. PMC: 3347462. DOI: 10.1128/IAI.00019-12. View

20.

Vandecandelaere I, Van Acker H, Coenye T . A Microplate-Based System as In Vitro Model of Biofilm Growth and Quantification. Methods Mol Biol. 2015; 1333:53-66. DOI: 10.1007/978-1-4939-2854-5_5. View